These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 921890)

  • 1. Alterations of mononuclear phagocyte function induced by Lewis lung carcinoma in C57BL mice.
    Otu AA; Russell RJ; Wilkinson PC; White RG
    Br J Cancer; 1977 Sep; 36(3):330-40. PubMed ID: 921890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The regulation of bone marrow-derived mononuclear phagocyte differentiation and mobilization in syngeneic and allogeneic YAC-lymphoma-bearing mice.
    Bursuker I; Goldman R
    Cell Tissue Kinet; 1982 Mar; 15(2):145-56. PubMed ID: 7066957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of macrophages and polymorphs in the levan-induced inhibition of Lewis lung carcinoma in C57BL mice.
    Leibovici J; Borit A; Sandbank U; Wolman M
    Br J Cancer; 1979 Oct; 40(4):597-607. PubMed ID: 497110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mononuclear phagocyte system in experimental chronic marrow failure.
    Gale RJ; Morley AA
    Exp Hematol; 1980 Jan; 8(1):16-24. PubMed ID: 7409034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of Lewis lung carcinoma growth by sera or spleen cells from tumour-bearing mice.
    Fray A; Thobie N; Liacopoulos P
    Ann Immunol (Paris); 1982; 133C(3):289-98. PubMed ID: 7149644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and humoral factors in host susceptibility to Lewis lung carcinoma.
    Gundersen S; Wibe E; Gidlund M; Godal T
    Acta Pathol Microbiol Scand C; 1981 Apr; 89(2):123-32. PubMed ID: 7293780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dusp3 deletion in mice promotes experimental lung tumour metastasis in a macrophage dependent manner.
    Vandereyken M; Jacques S; Van Overmeire E; Amand M; Rocks N; Delierneux C; Singh P; Singh M; Ghuysen C; Wathieu C; Zurashvili T; Sounni NE; Moutschen M; Gilles C; Oury C; Cataldo D; Van Ginderachter JA; Rahmouni S
    PLoS One; 2017; 12(10):e0185786. PubMed ID: 29020102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A quantitative and qualitative study of blood monocytes in patients with bronchogenic carcinoma.
    Nielsen H; Bennedsen J; Larsen SO; Dombernowsky P; Viskum K
    Cancer Immunol Immunother; 1982; 13(2):93-7. PubMed ID: 6297713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect on tumour colony formation of mouse serum associated with tumour resistance in vivo in semi syngeneic mice.
    Gundersen S; Wibe E; Funderud S; Grzenlak-Puczyinska I; Godal T
    Acta Pathol Microbiol Scand C; 1981 Aug; 89(4):223-8. PubMed ID: 7315358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of long-term cultures of proliferating, mononuclear phagocytes from bone marrow.
    van der Meer JW; van de Gevel JS; van Furth R
    J Reticuloendothel Soc; 1983 Sep; 34(3):203-25. PubMed ID: 6620253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage migratory dysfunction in cancer. A mechanism for subversion of surveillance.
    Snyderman R; Pike MC
    Am J Pathol; 1977 Sep; 88(3):727-39. PubMed ID: 196506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and functional characterization of a low molecular weight immune modulating factor produced by Lewis lung carcinoma.
    Young MR; Sundharadas G; Cantarow WD; Kumar PR
    Int J Cancer; 1982 Oct; 30(4):517-24. PubMed ID: 6754631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposing effects of dexamethasone on the clonal growth of granulocyte and macrophage progenitor cells and on the phagocytic capability of mononuclear phagocytes at different stages of differentiation.
    Shezen E; Shirman M; Goldman R
    J Cell Physiol; 1985 Sep; 124(3):545-53. PubMed ID: 4044663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive effects of the Lewis lung carcinoma.
    Klykken PC; Munson AE
    J Reticuloendothel Soc; 1979 Jun; 25(6):623-33. PubMed ID: 385867
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumor surveillance: how tumors may resist macrophage-mediated host defense.
    Rhodes J; Bishop M; Benfield J
    Science; 1979 Jan; 203(4376):179-82. PubMed ID: 758686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inflammation and host resistance against tumours. I. Delayed growth of Lewis tumour and inhibition of lung metastasis in mice having an inflammatory reaction distant from the inoculation site of tumour cells (author's transl)].
    Fauve RM; Hevin MB
    Ann Immunol (Paris); 1977; 128C(4-5):923-8. PubMed ID: 900902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of immune function and tumor growth inhibition by antibodies against prostaglandin E2.
    Young MR; Dizer M
    Immunol Commun; 1983; 12(1):11-23. PubMed ID: 6573300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repopulation of gamma-irradiated Lewis lung carcinoma by malignant cells and host macrophage progenitors.
    Stephens TC; Currie GA; Peacock JH
    Br J Cancer; 1978 Nov; 38(5):573-82. PubMed ID: 728347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Escherichia coli L-form cytoplasmic membranes on the interaction between macrophages and Lewis lung carcinoma cells: scanning electron microscopy.
    Ivanova EH; Michailova L; Stefanova Z; Neychev H; Radoevska S; Gumpert J
    FEMS Immunol Med Microbiol; 1997 Jan; 17(1):27-36. PubMed ID: 9012441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interplay of lymphoid cells and macrophages in tumour immunity.
    Alexander P; Evans R; Grant CK
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):645-58. PubMed ID: 5050874
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.